Z8779877149
Z8779877149 (Z7149) is a blood-brain barrier-permeable multi-target ligand that targets SERT (Ki=198 nM), α2A adrenergic receptor (Ki=180 nM; EC50=440 nM) and 5-HT2A receptor (EC50=172 nM, Emax=76%). Z8779877149 inhibits 5-HT reuptake and activates Gi and Gq protein signaling pathways, respectively. Z8779877149 effectively alleviates pain responses as well as depression- and anxiety-like behaviors, while exhibiting favorable safety without inducing sedation or motor impairment. Z8779877149 is available for the research of pain, depression and anxiety disorders.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C16H17F3N2O2
- 分子量:326.31
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
|
α2-adrenergic receptor 180 nM (Ki) |
5-HT2A Receptor 172 nM (EC50) |
α2-adrenergic receptor 440 nM (EC50) |
体外実験
Z8779877149 (z7149) (10-100 μM; 1 h for SERT complex formation) binds to the orthosteric pockets of human α2A adrenergic receptor and human SERT in conformations largely consistent with docking predictions, as confirmed by cryo-EM structures[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | Cmax | Brain Concentration | T1/2 |
|---|---|---|---|---|---|
| Mice[1] | 10 mg/kg | i.p. | 79.7 μM | 830 nM | 56 min |
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (8-10 week-old male; 10-12 week-old male and female); α2A D79N mutant (7-8 week-old female); α2a knockout; VMAT2 heterozygous[1]
-
Dosage:0.2 mg/kg (acute antidepressant-like activity); 0.25 mg/kg (anxiolytic-like activity); 0.5 mg/kg (antidepressant-like activity, acute and long-lasting); 10 mg/kg (analgesia, motor function, reward-related behavior); 20 mg/kg (analgesia); 30 mg/kg (analgesia)
-
Administration:i.p.
-
Result:Produced significant analgesia at 10 mg/kg; produced greater analgesic effects at 20 mg/kg and 30 mg/kg (increased withdrawal latency vs baseline).
Reduced CFA-induced thermal hypersensitivity at 10 mg/kg (significantly increased withdrawal latency vs vehicle-treated CFA mice).
Reduced SNI-induced mechanical allodynia at 10 mg/kg (significantly increased mechanical threshold vs vehicle-treated SNI mice).
Failed to produce significant analgesia at 10 mg/kg in α2A knockout mice.
Significantly increased punished crossings at 0.25 mg/kg, reaching an effect comparable to 0.5 mg/kg diazepam.
Reduced immobility time acutely at 0.2 mg/kg and 0.5 mg/kg with efficacy comparable to 20 mg/kg fluoxetine.
Maintained antidepressant-like efficacy for up to 5 days at 0.5 mg/kg, while fluoxetine efficacy declined by day 3.
Did not induce sedation or motor impairment at 10 mg/kg.
Did not induce conditioned place preference at 10 mg/kg.
化学情報
-
分子量 326.31
-
分子式 C16H17F3N2O2
-
SMILES
CN1C=CC2=C1C=C(C3=CCCNC3)C=C2.OC(C(F)(F)F)=O
-
別名
Z7149
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Z8779877149
- Z7149
- Z 8779877149
- Z-8779877149
- Z 7149
- Z-7149
- Serotonin Transporter
- Adrenergic Receptor
- 5-HT Receptor
- 5-HTT
- SERT
- SLC6A4
- Beta Receptor
- Serotonin Receptor
- 5-hydroxytryptamine Receptor
- depression
- anxiety
- 5-HT2A receptors
- Gq protein signaling
- mouse models
- α2A adrenergic receptors
- G? protein signaling
- pain
- cryo-EM structures
- Inhibitor
- inhibitor
- inhibit